Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements

Molecular Biology of the Cell

Volumn 10, Issue 4, 1999, Pages 907-919

  Dibbens, J A ^a   Miller, D L ^a   Damert, A ^b   Risau, W ^b   Vadas, M A ^a   Goodall, G J ^a  

^a HANSON INSTITUTE   (Australia)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; GENE CONTROL; GENE EXPRESSION; HYPOXIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STABILITY; REGULATORY MECHANISM; RNA DEGRADATION; RNA STRUCTURE;

ANIMALIA;

EID: 0032941747     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.4.907     Document Type: Article

References (52)

1. Battegay, E.J. (1995). Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J. Mol. Med. 73, 333-346.
2. Benjamin, L.E., and Keshet, E. (1997). Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangio-blastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA 94, 8761-8766.
3. Breier, G., Albrecht, U., Sterrer, S., and Risau, W. (1992). Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521-532.
4. Brown, C.Y., Lagnado, C.A., and Goodall, G.J. (1996). A cytokine mRNA-destabilizing element that is structurally and functionally distinct from A+U-rich elements. Proc. Natl. Acad. Sci. USA 93, 13721-13725.
5. Carmeliet, P., et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
6. 2-terminal kinase pathway. Science 280, 1945-1949.
7. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
8. Claffey, K.P., Shih, S.C., Mullen, A., Dziennis, S., Cusick, J.L., Abrams, K.R., Lee, S.W., and Detmar, M. (1998). Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol. Biol. Cell 9, 469-481.
9. Cohen, T., Gitay-Goren, H., Sharon, R., Shibuya, M., Halaban, R., Levi, B.Z., and Neufeld, G. (1995). VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J. Biol. Chem. 270, 11322-11326.
10. Czyzyk-Krzeska, M.F., and Beresh, J.E. (1996). Characterization of the hypoxia-inducible protein binding site within the pyrimidine-rich tract in the 3′-untranslated region of the tyrosine hydroxylase mRNA. J. Biol. Chem. 271, 3293-3299.
11. Czyzyk-Krzeska, M.F., Furnari, B.A., Lawson, E.E., and Millhorn, D.E. (1994). Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC12) cells. J. Biol. Chem. 269, 760-764.
12. Czyzyk-Krzeska, M.F., Paulding, W.R., Beresh, J.E., and Kroll, S.L. (1997). Posttranscriptional regulation of tyrosine hydroxylase gene expression by oxygen in PC12 cells. Kidney Int. 51, 585-590.
13. Damert, A., Machein, M., Breier, G., Fujita, M.Q., Hanahan, D., Risau, W., and Plate, K.H. (1997). Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res. 57, 3860-3864.
14. Enholm, B., et al. (1997). Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14, 2475-2483.
15. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powell-Braxton, L., Hillan, K.J., and Moore, M.W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
16. Folkman, J., and Shing, Y. (1992). Angiogenesis. J. Biol. Chem. 267, 10931-10934.
17. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D., and Semenza, G.L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613.
18. Goldberg, M.A., Gaut, C.C., and Bunn, H.F. (1991). Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood 77, 271-277.
19. Graven, K.K., Troxler, R.F., Kornfeld, H., Panchenko, M.V., and Farber, H.W. (1994). Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J. Biol. Chem. 269, 24446-24453.
20. Herrick, D.J., and Ross, J. (1994). The half-life of c-myc mRNA in growing and serum-stimulated cells: influence of the coding and 3′ untranslated regions and role of ribosome translocation. Mol. Cell. Biol. 14, 2119-2128.
21. Houck, K.A., Ferrara, N., Winer, J., Cachianes, G., Li, B., and Leung, D.W. (1991). The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5, 1806-1814.
22. Ikeda, E., Achen, M.G., Breier, G., and Risau, W. (1995). Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270, 19761-19766.
23. Iliopoulos, O., Levy, A.P., Jiang, C., Kaelin, W.G., Jr., and Goldberg, M.A. (1996). Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA 93, 10595-10599.
24. Kabnick, K.S., and Housman, D.E. (1988). Determinants that contribute to cytoplasmic stability of human c-fos and β-globin mRNAs are located at several sites in each mRNA. Mol. Cell. Biol. 8, 3244-3250.
25. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S., and Ferrara, N. (1993). Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362, 841-844.
26. Lagnado, C.A., Brown, C.Y., and Goodall, G.J. (1994). AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell. Biol. 14, 7984-7995.
27. Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V., and Ferrara, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
28. Levy, N.S., Chung, S., Furneaux, H., and Levy, A.P. (1998). Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273, 6417-6423.
29. Levy, N.S., Goldberg, M.A., and Levy, A.P. (1997). Sequencing of the human vascular endothelial growth factor (VEGF) 3′ untranslated region (UTR): conservation of five hypoxia-inducible RNA protein binding sites. Biochim. Biophys. Acta 1352, 167-173.
30. Levy, A.P., Levy, N.S., and Goldberg, M.A. (1996a). Posttranscriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271, 2746-2753.
31. Levy, A.P., Levy, N.S., and Goldberg, M.A. (1996b). Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J. Biol. Chem. 272, 25492-25497.
32. Levy, A.P., Levy, N.S., Wegner, S., and Goldberg, M.A. (1995). Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270, 13333-13340.
33. McGary, E.C., Rondon, I.J., and Beckman, B.S. (1997). Posttranscriptional regulation of erythropoietin mRNA stability by erythropoietin mRNA-binding protein. J. Biol. Chem. 272, 8628-8634.
34. Millauer, B., Shawver, L.K., Plate, K.H., Risau, W., and Ullrich, A. (1994). Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576-579.
35. Myer, V.E., Fan, X.C., and Steitz, J.A. (1997). Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J. 26, 2130-2139.
36. Plate, K.H., Breier, G., Weich, H.A., and Risau, W. (1992). Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359, 845-848.
37. Ponte, P., Gunning, P., Blau, H., and Kedes, L. (1983). Human actin genes are single copy for α-skeletal and α-cardiac actin but multicopy for β-and gamma-cytoskeletal genes: 3′ untranslated regions are isotype specific but are conserved in evolution. Mol. Cell. Biol. 3, 1783-1791.
38. Rivera, V.M., Sheng, M., and Greenberg, M.E. (1990). The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation. Genes Dev. 4, 255-268.
39. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
40. Semenza, G.L., and Wang, G.L. (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447-5454.
41. Shaw, J., Meerovitch, K., Bleackley, R.C., and Paetkau, V. (1988). Mechanisms regulating the level of IL-2 mRNA in T lymphocytes. J. Immunol. 140, 2243-2248.
42. Shima, D.T., Deutsch, U., and D'Amore, P.A. (1995). Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett. 370, 203-208.
43. Shima, D.T., Kuroki, M., Deutsch, U., Ng, Y.S., Adamis, A.P., and D'Amore, P.A. (1996). The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and posttranscriptional regulatory sequences. J. Biol. Chem. 271, 3877-3883.
44. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
45. Shweiki, D., Neeman, M., Itin, A., and Keshet, E. (1995). Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc. Natl. Acad. Sci. USA 92, 768-772.
46. Shyu, A.B., Greenberg, M.E., and Belasco, J.G. (1989). The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3, 60-72.
47. Stein, I., Neeman, M., Shweiki, D., Itin, A., and Keshet, E. (1995). Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15, 5363-5368.
48. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J.C., and Abraham, J.A. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954.
49. White, F.C., Carroll, S.M., and Kamps, M.P. (1995). VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF-overexpressing human tumor cell lines. Growth Factors 12, 289-301.
50. Wisdom, R., and Lee, W. (1991). The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5, 232-243.
51. Yang, L., Steussy, C.N., Fuhrer, D.K., Hamilton, J., and Yang, Y.C. (1996). Interleukin-11 mRNA stabilization in phorbol ester-stimulated primate bone marrow stromal cells. Mol. Cell. Biol. 16, 3300-3307.
52. Zubiaga, A.M., Belasco, J.G., and Greenberg, M.E. (1995). The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell. Biol. 15, 2219-2230.